Kikuyu drug maker to produce new once-a-month HIV prevention pill
Universal Corporation Limited (UCL), a pharmaceutical manufacturer based in Kikuyu, has been selected by global drug company Merck as one of only seven manufacturers worldwide licensed to produce alimatravir, an experimental HIV prevention medicine that is currently in Phase 3 clinical trials.










